Cargando…
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
The globalization of pharmaceutical production has not been accompanied by a strengthening and harmonization of the regulatory systems worldwide. Thus, the global market is characterized today by a situation of multiple standards, and patients in low- and middle-income countries are exposed to the r...
Autores principales: | Ravinetto, Raffaella, Vandenbergh, Daniel, Macé, Cécile, Pouget, Corinne, Renchon, Brigitte, Rigal, Jean, Schiavetti, Benedetta, Caudron, Jean-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105267/ https://www.ncbi.nlm.nih.gov/pubmed/27843547 http://dx.doi.org/10.1186/s40545-016-0088-0 |
Ejemplares similares
-
Pharmaceutical quality assurance of local private distributors: a secondary analysis in 13 low-income and middle-income countries
por: Van Assche, Kerlijn, et al.
Publicado: (2018) -
Quality assurance of medicines supplied to low-income and middle-income countries: poor products in shiny boxes?
por: Nebot Giralt, A, et al.
Publicado: (2017) -
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
por: Nebot Giralt, Ariadna, et al.
Publicado: (2020) -
A simplified checklist for the visual inspection of finished pharmaceutical products: a way to empower frontline health workers in the fight against poor-quality medicines
por: Schiavetti, B., et al.
Publicado: (2020) -
How the concept of WHO-listed authorities will change international procurement policies for medicines
por: Macé, Cécile, et al.
Publicado: (2022)